Moderna stock falls 20% after record rally as valuation concerns emerge
Covered by 1 source · 1 article
Moderna shares fell sharply in trading on Thursday as investors took profits after the biotechnology company posted its biggest one-day gain following positive Phase 3 cancer vaccine results. The retreat also came as analysts raised their p…
Covered by
